Have a personal or library account? Click to login
In vitro effects of ascorbic acid on viability and metabolism of patients’ osteosarcoma stem cells Cover

In vitro effects of ascorbic acid on viability and metabolism of patients’ osteosarcoma stem cells

Open Access
|Oct 2022

Abstract

Stagnation in novelties of osteosarcoma (OS) treatment indicates the need for new therapeutic methods. OS cancer stem cells (OS-CSC) are taught to have the ability to self-renew and develop mechanisms of anticancer drug resistance, and this is why it is difficult to eradicate them. Their metabolism has been recognized as a potential target of therapeutic action. Ascorbic acid (AA) is considered to act pro-oxidative against OS-CSC in vitro by oxidative effect and by inhibition of glycolysis. This study examined an in vitro impact of AA on OS-CSC metabolism isolated from patients’ biopsies, with the aim of better understanding of OS-CSC metabolism and the action of AA on OS-CSC. OS-CSC were isolated using a sphere culture system and identified as stem cells using Hoechst 33342 exclusion assay. Determination of the dominant type of metabolism of OS-CSC, parental OS cells, human mesenchymal stem cells (hMSC) and U2OS OS lineage before and after AA treatment was done by Seahorse XF (Agilent). Cytotoxicity of high-dose AA was confirmed by the MTT test and was proven for all the examined cell types as well as HEK293. Seahorse technology showed that OS-CSC can potentially use both glycolysis and oxidative phosphorylation (OXPHOS), and can turn to glycolysis and slow metabolic potential in unfavorable conditions such as incubation in AA.

DOI: https://doi.org/10.2478/acph-2022-0040 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 599 - 613
Accepted on: Jul 19, 2022
Published on: Oct 18, 2022
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2022 Marijana Šimić Jovičić, Maja Pušić, Maja Antunović, Maja Ledinski, Lucija Librenjak, Robert Kolundžić, Tomislav Ribičić, Vladimir Trkulja, Inga Urlić, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.